Ares Acquisition [AACT] vs Inflection Point [IPXX] Detailed Stock Comparison

Ares Acquisition

Inflection Point
TLDR: Quick Comparison Summary
We found some data (4 metrics), but not enough for a complete comparison. Metrics like P/E ratio, profitability, and financial health are still available in the detailed tabs below.
View Metrics Details
Vital Metrics Comparison
Note: Limited metrics are available for comparison. Check other tabs for more detailed analysis.
Metric | Ares Acquisition | Inflection Point | Better |
---|---|---|---|
P/E Ratio (TTM) | 36.50 | N/A | N/A |
Price-to-Book Ratio | 0.86 | 0.64 | Inflection Point |
Debt-to-Equity Ratio | 0.01 | 0.00 | Inflection Point |
PEG Ratio | -0.40 | N/A | N/A |
EV/EBITDA | -20.13 | N/A | N/A |
Profit Margin (TTM) | 0.00% | N/A | N/A |
Operating Margin (TTM) | 0.00% | N/A | N/A |
Return on Equity | 4.92% | N/A | N/A |
Return on Assets (TTM) | -1.04% | N/A | N/A |
Free Cash Flow (TTM) | $-929,804 | N/A | N/A |
1-Year Return | -31.46% | 70.69% | Inflection Point |
Enterprise Value | $594.62M | $0 | Ares Acquisition |
Revenue per Share (TTM) | $0 | N/A | N/A |
Earnings per Share (Diluted) | $0.26 | N/A | N/A |
Beta (Stock Volatility) | -0.01 | N/A | N/A |
Ares Acquisition vs Inflection Point Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
Stock | 1D | 1W | 1M | 3M | 6M | YTD |
---|---|---|---|---|---|---|
Ares Acquisition | 8.78% | 8.63% | -34.88% | -34.25% | -33.30% | -32.27% |
Inflection Point | 14.31% | 49.80% | 88.66% | 161.43% | 299.38% | 109.86% |
Long-term Returns
Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
---|---|---|---|---|---|---|
Ares Acquisition | -31.46% | -26.51% | -26.51% | -26.51% | -26.51% | -26.51% |
Inflection Point | 70.69% | 81.64% | 81.64% | 81.64% | 81.64% | 81.64% |
News Based Sentiment: Ares Acquisition vs Inflection Point
Ares Acquisition
News based Sentiment: MIXED
The month saw significant funding secured for the Ares/Kodiak merger, alongside substantial institutional investment. However, the stock experienced volatility and analysts maintain a 'Hold' rating, creating a mixed investment narrative. The upcoming shareholder meeting is a key catalyst.
Inflection Point
News based Sentiment: NEUTRAL
The month's narrative centers around increased visibility for IPXX as a small-cap stock, but the reports also highlight the inherent risks of this market segment. While positive in terms of attention, the overall impact on the investment case is neutral, requiring further investigation.
Performance & Financial Health Analysis: Ares Acquisition vs Inflection Point
Metric | AACT | IPXX |
---|---|---|
Market Information | ||
Market Cap | $421.26M | $811.25M |
Market Cap Category | Small cap | Small cap |
10 Day Avg. Volume | 870,233 | 11,317,539 |
90 Day Avg. Volume | 607,118 | 6,956,464 |
Last Close | $7.43 | $25.96 |
52 Week Range | $5.77 - $11.62 | $5.56 - $28.25 |
% from 52W High | -36.06% | -8.11% |
All-Time High | $11.62 (Jun 02, 2025) | $28.25 (Oct 03, 2025) |
% from All-Time High | -36.06% | -8.11% |
Growth Metrics | ||
Quarterly Revenue Growth | N/A | N/A |
Quarterly Earnings Growth | -0.95% | N/A |
Financial Health | ||
Profit Margin (TTM) | 0.00% | N/A |
Operating Margin (TTM) | 0.00% | N/A |
Return on Equity (TTM) | 0.05% | N/A |
Debt to Equity (MRQ) | 0.01 | 0.00 |
Cash & Liquidity | ||
Book Value per Share (MRQ) | $-0.39 | $40.57 |
Cash per Share (MRQ) | $0.00 | $0.02 |
Operating Cash Flow (TTM) | $-2,491,593 | $0 |
Levered Free Cash Flow (TTM) | $942,876 | $0 |
Dividends | ||
Last 12-Month Dividend Yield | N/A | N/A |
Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Ares Acquisition vs Inflection Point
Metric | AACT | IPXX |
---|---|---|
Price Ratios | ||
P/E Ratio (TTM) | 36.50 | N/A |
Forward P/E | N/A | N/A |
PEG Ratio | -0.40 | N/A |
Price to Sales (TTM) | N/A | N/A |
Price to Book (MRQ) | 0.86 | 0.64 |
Market Capitalization | ||
Market Capitalization | $421.26M | $811.25M |
Enterprise Value | $594.62M | $0 |
Enterprise Value Metrics | ||
Enterprise to Revenue | N/A | N/A |
Enterprise to EBITDA | -20.13 | N/A |
Risk & Other Metrics | ||
Beta | -0.01 | N/A |
Book Value per Share (MRQ) | $-0.39 | $40.57 |
Financial Statements Comparison: Ares Acquisition vs Inflection Point
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
Metric (MRQ) | AACT | IPXX |
---|---|---|
Revenue/Sales | $0 | $0 |
Cost of Goods Sold | N/A | N/A |
Gross Profit | N/A | N/A |
Research & Development | N/A | N/A |
Operating Income (EBIT) | $-2.71M | $-1.92M |
EBITDA | $-8.40M | $-5.35M |
Pre-Tax Income | $2.99M | $1.51M |
Income Tax | N/A | N/A |
Net Income (Profit) | $2.99M | $1.51M |
Balance Sheet & Liquidity Metrics (MRQ)
Metric (MRQ) | AACT | IPXX |
---|---|---|
Cash & Equivalents | $657,314 | $141,201 |
Total Current Assets | $747,611 | $222,948 |
Total Current Liabilities | $3.09M | $2.73M |
Long-Term Debt | $5.00M | N/A |
Total Shareholders Equity | $531.65M | $253.54M |
Retained Earnings | $-24.75M | $-15.60M |
Property, Plant & Equipment | N/A | N/A |
Cash Flow Statement Comparison (MRQ)
Metric (MRQ) | AACT | IPXX |
---|---|---|
Operating Cash Flow | $2.99M | $1.51M |
Capital Expenditures | N/A | N/A |
Free Cash Flow | $-318,005 | $-490,386 |
Debt Repayment | N/A | $0 |
Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
Metric | AACT | IPXX |
---|---|---|
Shares Short | 26,618 | N/A |
Short Ratio | 0.10 | N/A |
Short % of Float | 0.00% | N/A |
Average Daily Volume (10 Day) | 870,233 | 11,317,539 |
Average Daily Volume (90 Day) | 607,118 | 6,956,464 |
Shares Outstanding | 62.50M | 31.25M |
Float Shares | 39.98M | N/A |
% Held by Insiders | N/A | N/A |
% Held by Institutions | N/A | N/A |
Dividend Analysis & Yield Comparison: Ares Acquisition vs Inflection Point
Metric | AACT | IPXX |
---|---|---|
Last 12-Month Dividend | N/A | N/A |
Last 12-Month Dividend Yield | N/A | N/A |
3-Year Avg Annual Dividend | N/A | N/A |
3-Year Avg Dividend Yield | N/A | N/A |
3-Year Total Dividends | N/A | N/A |
Ex-Dividend Date | N/A | N/A |